{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T15:16:44Z","timestamp":1787498204691,"version":"build-2736575974"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T00:00:00Z","timestamp":1763424000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T00:00:00Z","timestamp":1763424000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"The Joint Project on Regional High-Incidence Diseases Research of Guangxi Natural Science Foundation","award":["2025GXNSFDA069051"],"award-info":[{"award-number":["2025GXNSFDA069051"]}]},{"name":"Guangxi Science and Technology Program","award":["GKE-ZZ202519"],"award-info":[{"award-number":["GKE-ZZ202519"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Med"],"DOI":"10.1007\/s10238-025-01953-z","type":"journal-article","created":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T02:40:20Z","timestamp":1763433620000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Integrated machine learning and single-cell analysis identify chromatin-remodeling gene signature for diagnosis and prognosis in nasopharyngeal carcinoma"],"prefix":"10.1007","volume":"26","author":[{"given":"Yuanyuan","family":"Chang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanting","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiling","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyu","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuhan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodong","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,18]]},"reference":[{"key":"1953_CR1","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/S0140-6736(19)30956-0","volume":"394","author":"YP Chen","year":"2019","unstructured":"Chen YP, Chan AT, Le QT, Blanchard P, Sun Y, Ma J. Nasopharyngeal carcinoma. Lancet. 2019;394:64\u201380. https:\/\/doi.org\/10.1016\/S0140-6736(19)30956-0.","journal-title":"Lancet"},{"key":"1953_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2024.102613","volume":"104","author":"Q Liu","year":"2025","unstructured":"Liu Q, Wang H, Chen Z, et al. Global, regional, and national epidemiology of nasopharyngeal carcinoma in middle-aged and elderly patients from 1990 to 2021. Ageing Res Rev. 2025;104:102613. https:\/\/doi.org\/10.1016\/j.arr.2024.102613.","journal-title":"Ageing Res Rev"},{"key":"1953_CR3","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229\u201363. https:\/\/doi.org\/10.3322\/caac.21834.","journal-title":"CA Cancer J Clin"},{"key":"1953_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2019.101890","volume":"79","author":"AWM Lee","year":"2019","unstructured":"Lee AWM, Ng WT, Chan JYW, et al. Management of locally recurrent nasopharyngeal carcinoma. Cancer Treat Rev. 2019;79:101890. https:\/\/doi.org\/10.1016\/j.ctrv.2019.101890.","journal-title":"Cancer Treat Rev"},{"key":"1953_CR5","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.it.2025.03.007","volume":"46","author":"L Yuan","year":"2025","unstructured":"Yuan L, Zhong L, Krummenacher C, Zhao Q, Zhang X. Epstein-Barr virus-mediated immune evasion in tumor promotion. Trends Immunol. 2025;46:386\u2013402. https:\/\/doi.org\/10.1016\/j.it.2025.03.007.","journal-title":"Trends Immunol"},{"key":"1953_CR6","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1001\/jamaoncol.2025.2191","volume":"11","author":"F Xue","year":"2025","unstructured":"Xue F, Ou D, Xie C, et al. Sequential vs induction plus concurrent chemoradiotherapy in nasopharyngeal carcinoma: a randomized clinical trial. JAMA Oncol. 2025;11:1011\u201320. https:\/\/doi.org\/10.1001\/jamaoncol.2025.2191.","journal-title":"JAMA Oncol"},{"key":"1953_CR7","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.r652","volume":"389","author":"M Xu","year":"2025","unstructured":"Xu M, Yang S, Cui E, Wang Z, Li X. Induction chemotherapy for nasopharyngeal carcinoma. BMJ (Clin Res Ed). 2025;389:r652. https:\/\/doi.org\/10.1136\/bmj.r652.","journal-title":"BMJ (Clin Res Ed)"},{"key":"1953_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2024.102840","volume":"131","author":"M Cai","year":"2024","unstructured":"Cai M, Wang Y, Ma H, Yang L, Xu Z. Advances and challenges in immunotherapy for locally advanced nasopharyngeal carcinoma. Cancer Treat Rev. 2024;131:102840. https:\/\/doi.org\/10.1016\/j.ctrv.2024.102840.","journal-title":"Cancer Treat Rev"},{"key":"1953_CR9","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1111\/nyas.70005","volume":"1551","author":"X Zhang","year":"2025","unstructured":"Zhang X, Liu D, Chen X, Li T, Wu G. Chromatin and epigenetic regulation in malignant tumors: a comprehensive review. Ann N Y Acad Sci. 2025;1551:33\u201351. https:\/\/doi.org\/10.1111\/nyas.70005.","journal-title":"Ann N Y Acad Sci"},{"key":"1953_CR10","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1038\/s41573-024-00978-5","volume":"23","author":"HA Malone","year":"2024","unstructured":"Malone HA, Roberts CWM. Chromatin remodellers as therapeutic targets. Nat Rev Drug Discov. 2024;23:661\u201381. https:\/\/doi.org\/10.1038\/s41573-024-00978-5.","journal-title":"Nat Rev Drug Discov"},{"key":"1953_CR11","doi-asserted-by":"publisher","first-page":"1530578","DOI":"10.3389\/fendo.2025.1530578","volume":"16","author":"X Zhang","year":"2025","unstructured":"Zhang X, Liu D, Yin S, Gao Y, Li X, Wu G. Metabolism and epigenetics in cancer: toward personalized treatment. Front Endocrinol. 2025;16:1530578. https:\/\/doi.org\/10.3389\/fendo.2025.1530578.","journal-title":"Front Endocrinol"},{"key":"1953_CR12","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1038\/s41420-025-02667-7","volume":"11","author":"H Goyal","year":"2025","unstructured":"Goyal H, Kaur J. Long non-coding RNAs and autophagy: dual drivers of hepatocellular carcinoma progression. Cell Death Discov. 2025;11:376. https:\/\/doi.org\/10.1038\/s41420-025-02667-7.","journal-title":"Cell Death Discov"},{"key":"1953_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/s41698-025-01003-7","volume":"9","author":"HE Marei","year":"2025","unstructured":"Marei HE. Epigenetic regulators in cancer therapy and progression. NPJ Precis Oncol. 2025;9:206. https:\/\/doi.org\/10.1038\/s41698-025-01003-7.","journal-title":"NPJ Precis Oncol"},{"key":"1953_CR14","doi-asserted-by":"publisher","DOI":"10.1172\/JCI163450","volume":"133","author":"BL McClellan","year":"2023","unstructured":"McClellan BL, Haase S, Nunez FJ, et al. Impact of epigenetic reprogramming on antitumor immune responses in glioma. J Clin Invest. 2023;133:e163450. https:\/\/doi.org\/10.1172\/JCI163450.","journal-title":"J Clin Invest"},{"key":"1953_CR15","doi-asserted-by":"publisher","first-page":"5743","DOI":"10.1158\/0008-5472.CAN-16-0268","volume":"76","author":"X He","year":"2016","unstructured":"He X, Yan B, Liu S, et al. Chromatin remodeling factor LSH drives cancer progression by suppressing the activity of fumarate hydratase. Cancer Res. 2016;76:5743\u201355. https:\/\/doi.org\/10.1158\/0008-5472.CAN-16-0268.","journal-title":"Cancer Res"},{"key":"1953_CR16","doi-asserted-by":"publisher","first-page":"6931","DOI":"10.7150\/jca.63333","volume":"12","author":"Y Xie","year":"2021","unstructured":"Xie Y, Wang H, Wang S, et al. Clinicopathological significance of ATRX expression in nasopharyngeal carcinoma patients: a retrospective study. J Cancer. 2021;12:6931\u20136. https:\/\/doi.org\/10.7150\/jca.63333.","journal-title":"J Cancer"},{"key":"1953_CR17","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1186\/s13046-022-02457-4","volume":"41","author":"J Jiang","year":"2022","unstructured":"Jiang J, Ying H. Revealing the crosstalk between nasopharyngeal carcinoma and immune cells in the tumor microenvironment. J Exp Clin Cancer Res. 2022;41:244. https:\/\/doi.org\/10.1186\/s13046-022-02457-4.","journal-title":"J Exp Clin Cancer Res"},{"key":"1953_CR18","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie ME, Phipson B, Wu D, et al. Limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43:e47. https:\/\/doi.org\/10.1093\/nar\/gkv007.","journal-title":"Nucleic Acids Res"},{"key":"1953_CR19","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1186\/1471-2105-9-559","volume":"9","author":"P Langfelder","year":"2008","unstructured":"Langfelder P, Horvath S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinform. 2008;9:559. https:\/\/doi.org\/10.1186\/1471-2105-9-559.","journal-title":"BMC Bioinform"},{"key":"1953_CR20","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/75556","volume":"25","author":"M Ashburner","year":"2000","unstructured":"Ashburner M, Ball CA, Blake JA, et al. Gene ontology: tool for the unification of biology. The gene ontology consortium. Nat Genet. 2000;25:25\u20139. https:\/\/doi.org\/10.1038\/75556.","journal-title":"Nat Genet"},{"key":"1953_CR21","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa M, Goto S. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 2000;28:27\u201330. https:\/\/doi.org\/10.1093\/nar\/28.1.27.","journal-title":"Nucleic Acids Res"},{"key":"1953_CR22","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu G, Wang L-G, Han Y, He Q-Y. clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS. 2012;16:284\u20137. https:\/\/doi.org\/10.1089\/omi.2011.0118.","journal-title":"OMICS"},{"key":"1953_CR23","doi-asserted-by":"publisher","first-page":"2652","DOI":"10.3390\/nu12092652","volume":"12","author":"AJ McEligot","year":"2020","unstructured":"McEligot AJ, Poynor V, Sharma R, Panangadan A. Logistic LASSO regression for dietary intakes and breast cancer. Nutrients. 2020;12:2652. https:\/\/doi.org\/10.3390\/nu12092652.","journal-title":"Nutrients"},{"key":"1953_CR24","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1111\/j.1467-9868.2007.00627.x","volume":"70","author":"L Meier","year":"2008","unstructured":"Meier L, Van De Geer S, B\u00fchlmann P. The group lasso for logistic regression. J R Stat Soc Ser B Stat Methodol. 2008;70:53\u201371. https:\/\/doi.org\/10.1111\/j.1467-9868.2007.00627.x.","journal-title":"J R Stat Soc Ser B Stat Methodol"},{"key":"1953_CR25","doi-asserted-by":"publisher","first-page":"271","DOI":"10.3233\/FI-2010-288","volume":"101","author":"MB Kursa","year":"2010","unstructured":"Kursa MB, Jankowski A, Rudnicki WR. Boruta - a system for feature selection. Fundam Inform. 2010;101:271\u201385. https:\/\/doi.org\/10.3233\/FI-2010-288.","journal-title":"Fundam Inform"},{"key":"1953_CR26","doi-asserted-by":"publisher","first-page":"5381","DOI":"10.1002\/sim.5958","volume":"32","author":"P Blanche","year":"2013","unstructured":"Blanche P, Dartigues J-F, Jacqmin-Gadda H. Estimating and comparing time-dependent areas under receiver operating characteristic curves for censored event times with competing risks. Stat Med. 2013;32:5381\u201397. https:\/\/doi.org\/10.1002\/sim.5958.","journal-title":"Stat Med"},{"key":"1953_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-12-77","volume":"12","author":"X Robin","year":"2011","unstructured":"Robin X, Turck N, Hainard A, et al. pROC: an open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinformatics. 2011;12:77. https:\/\/doi.org\/10.1186\/1471-2105-12-77.","journal-title":"BMC Bioinformatics"},{"key":"1953_CR28","doi-asserted-by":"publisher","first-page":"1008146","DOI":"10.3389\/fimmu.2022.1008146","volume":"13","author":"J Huang","year":"2022","unstructured":"Huang J, Zhang J, Wang F, Zhang B, Tang X. Comprehensive analysis of cuproptosis-related genes in immune infiltration and diagnosis in ulcerative colitis. Front Immunol. 2022;13:1008146. https:\/\/doi.org\/10.3389\/fimmu.2022.1008146.","journal-title":"Front Immunol"},{"key":"1953_CR29","doi-asserted-by":"publisher","first-page":"W214","DOI":"10.1093\/nar\/gkq537","volume":"38","author":"D Warde-Farley","year":"2010","unstructured":"Warde-Farley D, Donaldson SL, Comes O, et al. The GeneMANIA prediction server: biological network integration for gene prioritization and predicting gene function. Nucleic Acids Res. 2010;38:W214-220. https:\/\/doi.org\/10.1093\/nar\/gkq537.","journal-title":"Nucleic Acids Res"},{"key":"1953_CR30","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1002\/cac2.12067","volume":"40","author":"J Wu","year":"2020","unstructured":"Wu J, Zhang H, Li L, et al. A nomogram for predicting overall survival in patients with low-grade endometrial stromal sarcoma: a population-based analysis. Cancer Commun. 2020;40:301\u201312. https:\/\/doi.org\/10.1002\/cac2.12067.","journal-title":"Cancer Commun"},{"key":"1953_CR31","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1177\/0272989X06295361","volume":"26","author":"AJ Vickers","year":"2006","unstructured":"Vickers AJ, Elkin EB. Decision curve analysis: a novel method for evaluating prediction models. Med Decis Mak Int J Soc Med Decis Mak. 2006;26:565\u201374. https:\/\/doi.org\/10.1177\/0272989X06295361.","journal-title":"Med Decis Mak Int J Soc Med Decis Mak"},{"key":"1953_CR32","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1038\/s41422-020-0374-x","volume":"30","author":"Y-P Chen","year":"2020","unstructured":"Chen Y-P, Yin J-H, Li W-F, et al. Single-cell transcriptomics reveals regulators underlying immune cell diversity and immune subtypes associated with prognosis in nasopharyngeal carcinoma. Cell Res. 2020;30:1024\u201342. https:\/\/doi.org\/10.1038\/s41422-020-0374-x.","journal-title":"Cell Res"},{"key":"1953_CR33","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/nbt.2859","volume":"32","author":"C Trapnell","year":"2014","unstructured":"Trapnell C, Cacchiarelli D, Grimsby J, et al. The dynamics and regulators of cell fate decisions are revealed by pseudotemporal ordering of single cells. Nat Biotechnol. 2014;32:381\u20136. https:\/\/doi.org\/10.1038\/nbt.2859.","journal-title":"Nat Biotechnol"},{"key":"1953_CR34","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2018.33.e303","volume":"33","author":"Y-H Kim","year":"2018","unstructured":"Kim Y-H, Byun YJ, Kim WT, et al. CDC6 mRNA expression is associated with the aggressiveness of prostate cancer. J Korean Med Sci. 2018;33:e303. https:\/\/doi.org\/10.3346\/jkms.2018.33.e303.","journal-title":"J Korean Med Sci"},{"key":"1953_CR35","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1038\/s41598-017-00998-9","volume":"7","author":"R Mahadevappa","year":"2017","unstructured":"Mahadevappa R, Neves H, Yuen SM, et al. The prognostic significance of Cdc6 and Cdt1 in breast cancer. Sci Rep. 2017;7:985. https:\/\/doi.org\/10.1038\/s41598-017-00998-9.","journal-title":"Sci Rep"},{"key":"1953_CR36","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1186\/s12943-022-01623-8","volume":"21","author":"F Wang","year":"2022","unstructured":"Wang F, Zhao F, Zhang L, et al. CDC6 is a prognostic biomarker and correlated with immune infiltrates in glioma. Mol Cancer. 2022;21:153. https:\/\/doi.org\/10.1186\/s12943-022-01623-8.","journal-title":"Mol Cancer"},{"key":"1953_CR37","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1186\/s13046-025-03472-x","volume":"44","author":"D Huang","year":"2025","unstructured":"Huang D, Chu X, Wu C, et al. CCNY-mediated phosphorylation and TET2-BACH1-driven DNA demethylation activate PRC1 to augment NSCLC progression. J Exp Clin Cancer Res. 2025;44:206. https:\/\/doi.org\/10.1186\/s13046-025-03472-x.","journal-title":"J Exp Clin Cancer Res"},{"key":"1953_CR38","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/j.biopha.2016.07.047","volume":"83","author":"V Brynychova","year":"2016","unstructured":"Brynychova V, Ehrlichova M, Hlavac V, et al. Genetic and functional analyses do not explain the association of high PRC1 expression with poor survival of breast carcinoma patients. Biomed Pharmacother. 2016;83:857\u201364. https:\/\/doi.org\/10.1016\/j.biopha.2016.07.047.","journal-title":"Biomed Pharmacother"},{"key":"1953_CR39","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1136\/gutjnl-2015-310625","volume":"65","author":"J Chen","year":"2016","unstructured":"Chen J, Rajasekaran M, Xia H, et al. The microtubule-associated protein PRC1 promotes early recurrence of hepatocellular carcinoma in association with the wnt\/\u03b2-catenin signalling pathway. Gut. 2016;65:1522\u201334. https:\/\/doi.org\/10.1136\/gutjnl-2015-310625.","journal-title":"Gut"},{"key":"1953_CR40","doi-asserted-by":"publisher","first-page":"5775","DOI":"10.2147\/CMAR.S308884","volume":"13","author":"M Wu","year":"2021","unstructured":"Wu M, Yang L, Hou X, Wang Z, Zhang J. Human polycomb protein 2 (hPC2) as a novel independent prognostic marker in nasopharyngeal carcinoma. Cancer Manag Res. 2021;13:5775\u201384. https:\/\/doi.org\/10.2147\/CMAR.S308884.","journal-title":"Cancer Manag Res"},{"key":"1953_CR41","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1515\/hsz-2019-0436","volume":"401","author":"SL Nutt","year":"2020","unstructured":"Nutt SL, Keenan C, Chopin M, Allan RS. EZH2 function in immune cell development. Biol Chem. 2020;401:933\u201343. https:\/\/doi.org\/10.1515\/hsz-2019-0436.","journal-title":"Biol Chem"},{"key":"1953_CR42","doi-asserted-by":"publisher","first-page":"83","DOI":"10.3390\/genes7100083","volume":"7","author":"Y Yao","year":"2016","unstructured":"Yao Y, Hu H, Yang Y, et al. Downregulation of enhancer of zeste homolog 2 (EZH2) is essential for the induction of autophagy and apoptosis in colorectal cancer cells. Genes. 2016;7:83. https:\/\/doi.org\/10.3390\/genes7100083.","journal-title":"Genes"},{"key":"1953_CR43","doi-asserted-by":"publisher","first-page":"3480","DOI":"10.1016\/j.celrep.2018.03.002","volume":"22","author":"T Ito","year":"2018","unstructured":"Ito T, Teo YV, Evans SA, Neretti N, Sedivy JM. Regulation of cellular senescence by polycomb chromatin modifiers through distinct DNA damage- and histone methylation-dependent pathways. Cell Rep. 2018;22:3480\u201392. https:\/\/doi.org\/10.1016\/j.celrep.2018.03.002.","journal-title":"Cell Rep"},{"key":"1953_CR44","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1158\/1535-7163.MCT-24-0693","volume":"24","author":"M Melino","year":"2025","unstructured":"Melino M, Tu WJ, Bielefeldt-Ohmann H, et al. Depleting the action of EZH2 through PI3K-mTOR inhibition to overcome metastasis and immunotherapy resistance in triple-negative breast cancer. Mol Cancer Ther. 2025;24:1511\u201326. https:\/\/doi.org\/10.1158\/1535-7163.MCT-24-0693.","journal-title":"Mol Cancer Ther"},{"key":"1953_CR45","doi-asserted-by":"publisher","first-page":"e20230561","DOI":"10.1084\/jem.20230561","volume":"221","author":"G Zou","year":"2024","unstructured":"Zou G, Huang Y, Zhang S, et al. E-cadherin loss drives diffuse-type gastric tumorigenesis via EZH2-mediated reprogramming. J Exp Med. 2024;221:e20230561. https:\/\/doi.org\/10.1084\/jem.20230561.","journal-title":"J Exp Med"},{"key":"1953_CR46","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.ygyno.2019.12.003","volume":"156","author":"L Krill","year":"2020","unstructured":"Krill L, Deng W, Eskander R, et al. Overexpression of enhance of zeste homolog 2 (EZH2) in endometrial carcinoma: an NRG oncology\/gynecologic oncology group study. Gynecol Oncol. 2020;156:423\u20139. https:\/\/doi.org\/10.1016\/j.ygyno.2019.12.003.","journal-title":"Gynecol Oncol"},{"key":"1953_CR47","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.cbi.2019.04.028","volume":"307","author":"M Yu","year":"2019","unstructured":"Yu M, Li Y, Li M, Lu D. Eudesmin exerts antitumor effects by down-regulating EZH2 expression in nasopharyngeal carcinoma cells. Chem Biol Interact. 2019;307:51\u20137. https:\/\/doi.org\/10.1016\/j.cbi.2019.04.028.","journal-title":"Chem Biol Interact"},{"key":"1953_CR48","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1093\/emboj\/21.1.175","volume":"21","author":"K Miyagawa","year":"2002","unstructured":"Miyagawa K, Tsuruga T, Kinomura A, et al. A role for RAD54B in homologous recombination in human cells. EMBO J. 2002;21:175\u201380. https:\/\/doi.org\/10.1093\/emboj\/21.1.175.","journal-title":"EMBO J"},{"key":"1953_CR49","doi-asserted-by":"publisher","first-page":"5426","DOI":"10.1038\/ncomms6426","volume":"5","author":"T Yasuhara","year":"2014","unstructured":"Yasuhara T, Suzuki T, Katsura M, Miyagawa K. Rad54B serves as a scaffold in the DNA damage response that limits checkpoint strength. Nat Commun. 2014;5:5426. https:\/\/doi.org\/10.1038\/ncomms6426.","journal-title":"Nat Commun"},{"key":"1953_CR50","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1186\/s13046-019-1149-4","volume":"38","author":"L Miao","year":"2019","unstructured":"Miao L, Liu HY, Zhou C, He X. LINC00612 enhances the proliferation and invasion ability of bladder cancer cells as ceRNA by sponging miR-590 to elevate expression of PHF14. J Exp Clin Cancer Res. 2019;38:143. https:\/\/doi.org\/10.1186\/s13046-019-1149-4.","journal-title":"J Exp Clin Cancer Res"},{"key":"1953_CR51","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1186\/s12935-019-1040-6","volume":"19","author":"S Wu","year":"2019","unstructured":"Wu S, Luo C, Li F, Hameed NUF, Jin Q, Zhang J. Silencing expression of PHF14 in glioblastoma promotes apoptosis, mitigates proliferation and invasiveness via wnt signal pathway. Cancer Cell Int. 2019;19:314. https:\/\/doi.org\/10.1186\/s12935-019-1040-6.","journal-title":"Cancer Cell Int"},{"key":"1953_CR52","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/6507510","volume":"2020","author":"Y Zhao","year":"2020","unstructured":"Zhao Y, He J, Li Y, et al. PHF14 promotes cell proliferation and migration through the AKT and ERK1\/2 pathways in gastric cancer cells. BioMed Res Int. 2020;2020:6507510. https:\/\/doi.org\/10.1155\/2020\/6507510.","journal-title":"BioMed Res Int"},{"key":"1953_CR53","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s13045-020-00937-8","volume":"13","author":"R Duan","year":"2020","unstructured":"Duan R, Du W, Guo W. EZH2: a novel target for cancer treatment. J Hematol Oncol. 2020;13:104. https:\/\/doi.org\/10.1186\/s13045-020-00937-8.","journal-title":"J Hematol Oncol"},{"key":"1953_CR54","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.ccell.2025.01.013","volume":"43","author":"P Porazzi","year":"2025","unstructured":"Porazzi P, Nason S, Yang Z, et al. EZH1\/EZH2 inhibition enhances adoptive T cell immunotherapy against multiple cancer models. Cancer Cell. 2025;43:537-551.e7. https:\/\/doi.org\/10.1016\/j.ccell.2025.01.013.","journal-title":"Cancer Cell"},{"key":"1953_CR55","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202308045","volume":"11","author":"J Huang","year":"2024","unstructured":"Huang J, Yin Q, Wang Y, et al. EZH2 inhibition enhances PD-L1 protein stability through USP22-mediated deubiquitination in colorectal cancer. Adv Sci. 2024;11:e2308045. https:\/\/doi.org\/10.1002\/advs.202308045.","journal-title":"Adv Sci"},{"key":"1953_CR56","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s12935-024-03629-2","volume":"25","author":"C Xu","year":"2025","unstructured":"Xu C, Liang L, Liu G, et al. Predicting hepatocellular carcinoma outcomes and immune therapy response with ATP-dependent chromatin remodeling-related genes, highlighting MORF4L1 as a promising target. Cancer Cell Int. 2025;25:4. https:\/\/doi.org\/10.1186\/s12935-024-03629-2.","journal-title":"Cancer Cell Int"},{"key":"1953_CR57","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.3390\/cancers11091270","volume":"11","author":"A Argentiero","year":"2019","unstructured":"Argentiero A, Solimando AG, Brunetti O, et al. Skeletal metastases of unknown primary: biological landscape and clinical overview. Cancers (Basel). 2019;11:1270. https:\/\/doi.org\/10.3390\/cancers11091270.","journal-title":"Cancers (Basel)"}],"container-title":["Clinical and Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-025-01953-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10238-025-01953-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-025-01953-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T02:40:21Z","timestamp":1763433621000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10238-025-01953-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,18]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1953"],"URL":"https:\/\/doi.org\/10.1007\/s10238-025-01953-z","relation":{},"ISSN":["1591-9528"],"issn-type":[{"value":"1591-9528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,18]]},"assertion":[{"value":"29 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics statement"}}],"article-number":"16"}}